
oct pm et
summari compani design manufactur market profession medic industri
commerci product servic global
price-to-earnings oper ep
risk assess reflect modest growth prospect
compani market good corpor
leadership solid balanc sheet compani
past perform indic futur perform reli upon
analysi prepar equiti analyst
oct stock trade
expect total revenu grow
billion billion
organ basi see revenu grow
grow drive higher
revenu ep growth invest
higher-technolog busi new
geograph market
billion acquisit dna technolog
portfolio restructur initi
led announc compani
intent spin-off dental busi
revenu lowest growth
profil oper margin
segment see divestitur expect
complet posit
prior spun-off
turn benefici
recent streamlin activ like help
expect ebitda margin
improv
margin achiev expect
effect tax rate vs
includ one-tim
benefit billion
think share trade
forward earn near fair valu
consist free cash flow gener
strong balanc sheet support
continu support abil make
acquisit could acceler ep
growth find manag
experienc make integr
acquisit compani
suffer margin degrad recent year
taken mani charg relat
acquisit tariff expect minor
headwind per quarter given
trade averag
forward pe think upsid potenti
acquisit captur
risk recommend target price
includ overpay acquisit failur
integr acquisit advers chang
foreign exchang rate
worse-than-expect impact tariff
particularli relat demand china
target price
ep estim
three-year averag forward multipl
compani increas
exposur attract market
jan ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview danah corpor design manufactur market profession
medic industri commerci product servic research develop manufactur
sale distribut servic administr facil locat countri
approxim sale deriv custom outsid busi broken
four segment life scienc revenu diagnost revenu dental
revenu environment appli solut revenu
life scienc offer broad rang research tool scientist use studi basic build block
life includ gene protein metabolit cell order understand caus diseas
identifi new therapi test new drug vaccin segment pall corpor pall
busi also lead provid filtrat separ purif technolog
biopharmaceut food beverag medic aerospac microelectron gener industri
sector sale segment geograph destin north america europ
asia/australia region
diagnost segment offer analyt instrument reagent consum softwar servic
hospit physician offic refer laboratori critic care set use diagnos
diseas make treatment decis sale segment geograph destin
north america europ asia/australia region
compani dental segment provid product use diagnos treat prevent diseas
ailment teeth gum support bone well improv aesthet human
smile compani lead world-wide provid broad rang dental consum equip
servic dedic drive technolog innov help dental profession improv
clinic outcom enhanc product sale segment geograph destin
north america europ asia/australia region
compani environment appli solut segment offer product servic help protect
import resourc keep global food water suppli safe sale segment
geograph destin north america europ asia/australia region
corpor strategi compani seek expand revenu combin intern growth
acquisit compani histori success acquisit expect compani
remain acquisit balanc sheet cash flow support activ april
close billion acquisit supplier custom nucleic acid
acquir ten busi total consider million cash net cash acquir dhr
activ mute compar acquir cepheid lead global molecular
diagnost compani total purchas price approxim billion seven busi
total consider million cash net cash acquir
impact major develop august acquir pall corp pll billion
conjunct purchas announc plan split two separ publicly-trad
compani first maintain name would combin pll life scienc
filtrat busi second name would includ industri busi includ test
measur spun sharehold juli sharehold
receiv one share share held
financi trend revenu grew year-over-year billion growth
partial driven acquisit year revenu growth continu oper
five-year cumul annual growth rate compound-annual-growth-rate free cash flow defin cash flow
oper less capit expenditur remain steadi last sever year
declin slightli billion
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
fairli valu
neutral sinc octob technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook health care
equip sub-industri next month
posit continu expect
compani sub-industri grow
posit macro environ addit
sub-industri mani product area
histor recession-resist
particularli equip use non-elect
procedur valuat continu high
industri driven expand margin
robust revenu growth compani
industri think lax food
drug administr fda
increas capabl technolog
enabl medic devic manufactur bring
innov product market faster
constant currenc basi expect
revenu sub-industri rise
high-single-digit low-double-digit
percentag driven continu pipelin
innov new product emerg market
expans speed new product
come market increas recent
year success effort
fda reduc approv time medic
devic time see price
pressur incess head wind medic
impact trade war appear mild
far medic equip compani
accord medic devic trade
septemb retaliatori tariff
billion us medic technolog export
although us chines govern
seek lower health care cost provid
equip manufactur insul
industri earlier commentari
medic devic manufactur suggest
impact trade war would manag
provid commentari impact
trade war earn
on-going threat state health
care system current us
administr continu attempt repeal
afford act stop
multipl time gather suffici
number vote pass variou repeal
replac bill recent on-going
lawsuit texa question
constitution
think import watch
mid-term elect novemb
health care appear import topic
hospit spend larg driver medic
equip sale robust
strong us economi
tax cut job act tcja individu
mandat roll think
hospit could see pressur lead
sale pressur medic equip
requir american health
insur without requir
expect lower number american
gener see posit long-term
fundament includ increas global
demand qualiti health care age
popul rise outlay lead
steadi flow innov product
 health equip
sub-index increas vs rise
 composit index year
date septemb
increas composit
base index
five-year market price perform oct
note sector sub-industri inform base
past perform indic futur perform
reli upon
becton dickinson compani
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
see demand environ like remain robust see share trade
near estim fair valu current level /jim corridor
maintain target price valu share
ep estim unchang today push valuat
year keep line averag keep ep
estim second quarter ep vs two cent
ahead forecast revenu slightli ahead expect
guid adjust ep modestli prior
guidanc see compani continu acquisit
see share trade near estim fair valu /j corridor
keep target price ep estim
unchang today line averag premium
peer warrant view like faster revenu growth better
oper margin peer ep vs cent
forecast penni ahead capit iq consensu slightli
better revenu project guid adjust ep
see compani continu acquisit see share
trade near estim fair valu /j corridor
analyst research note compani news
et cfra maintain hold opinion share
corpor lift target
ep estim multipl in-lin
peer multipl three-year averag forward multipl
compani increas exposur higher-growth market
acquisit ep vs higher estim
lift ep sale increas
organ billion organ revenu growth life scienc
segment environment diagnost dental
regard tariff expect million head wind per quarter
rel dhr quarterli revenu billion rel
insignific manag highlight pursu sever effort
mitig advers impact tariff includ reloc manufactur
facil make suppli chain chang pursu tariff exempt /kevin
et cfra maintain hold opinion share
corpor maintain target
ep estim multipl in-lin
three-year averag peer multipl ep vs
higher estim rais ep
sale increas organ billion organ revenu growth
life scienc segment diagnost dental
environment impress abil drive substanti
core oper margin improv life scienc diagnost
busi announc today intent spin tax-fre
transact sharehold dental segment independ
publicly-trad compani name dentalco expect transact
complet dental segment compris revenu
lowest growth profil lowest oper margin
et cfra keep hold opinion share corpor
keep target price valu share
ep estim rais today
line three year averag line peer multipl
risen rais ep estim first quarter
adjust ep vs beat estim consensu
revenu growth ahead expect report
good result organ revenu growth like deceler year versu
last year howev compani continu acquisit like
aid revenu guid adjust ep prior
guidanc posit posit market
segment strong track record revenu ep growth howev see
share trade near estim fair valu current level
rais target price
valu share ep estim unchang today
line three year averag line peer multipl
risen start ep estim fourth quarter
adjust ep vs beat estim consensu
revenu growth ahead expect get
ep boost tax reform see like deceler revenu growth
share seem close fair valu view /jim corridor
rais target price valu
share ep estim rais line
averag line peer median forward price-to-earnings
rais ep estim third quarter adjust ep
vs beat consensu revenu growth
better expect guid adjust ep
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
